David Haslam

6.5k total citations
183 papers, 4.0k citations indexed

About

David Haslam is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, David Haslam has authored 183 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 36 papers in Infectious Diseases and 30 papers in Epidemiology. Recurrent topics in David Haslam's work include Gut microbiota and health (25 papers), Diet and metabolism studies (21 papers) and Clostridium difficile and Clostridium perfringens research (17 papers). David Haslam is often cited by papers focused on Gut microbiota and health (25 papers), Diet and metabolism studies (21 papers) and Clostridium difficile and Clostridium perfringens research (17 papers). David Haslam collaborates with scholars based in United States, United Kingdom and Canada. David Haslam's co-authors include Min Yu, Rana E. El Feghaly, José B. Sáenz, Phillip I. Tarr, Jennifer L. Stauber, Mike Lean, Naveed Sattar, Jacques Baenziger, Staffan Normark and Jinmei Li and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David Haslam

164 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Haslam United States 33 1.3k 948 812 509 477 183 4.0k
Weidong Zhang China 31 1.1k 0.8× 656 0.7× 593 0.7× 354 0.7× 333 0.7× 209 4.6k
Jakob Begun Australia 30 1.7k 1.3× 428 0.5× 810 1.0× 648 1.3× 289 0.6× 106 3.9k
Tetsuya Matsumoto Japan 39 1.5k 1.1× 954 1.0× 1.2k 1.5× 1.4k 2.7× 348 0.7× 271 5.7k
Theodoros Kelesidis United States 38 1.2k 0.9× 1.4k 1.5× 2.0k 2.4× 582 1.1× 896 1.9× 159 6.5k
Anders Håkansson Sweden 43 1.5k 1.1× 677 0.7× 1.5k 1.9× 377 0.7× 146 0.3× 127 4.9k
Mitchell B. Cohen United States 44 1.2k 0.9× 1.1k 1.2× 593 0.7× 666 1.3× 475 1.0× 161 5.8k
Raphaëlle Bourdet‐Sicard France 21 1.1k 0.8× 444 0.5× 309 0.4× 360 0.7× 508 1.1× 40 2.9k
Michael J.G. Farthing United Kingdom 47 974 0.7× 1.7k 1.8× 837 1.0× 409 0.8× 866 1.8× 259 7.5k
Jan Rupp Germany 38 1.0k 0.8× 582 0.6× 1.4k 1.7× 988 1.9× 314 0.7× 216 4.2k
Susan M. Bueno Chile 42 1.4k 1.1× 1.3k 1.4× 1.8k 2.2× 1.9k 3.7× 301 0.6× 186 5.5k

Countries citing papers authored by David Haslam

Since Specialization
Citations

This map shows the geographic impact of David Haslam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Haslam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Haslam more than expected).

Fields of papers citing papers by David Haslam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Haslam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Haslam. The network helps show where David Haslam may publish in the future.

Co-authorship network of co-authors of David Haslam

This figure shows the co-authorship network connecting the top 25 collaborators of David Haslam. A scholar is included among the top collaborators of David Haslam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Haslam. David Haslam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pham, Giang, et al.. (2024). Complement-producing maternal microchimeric cells override infection susceptibility in complement-deficient murine offspring. Journal of Clinical Investigation. 135(1). 1 indexed citations
2.
Kharofa, Jordan, David Haslam, Allison Weiss, et al.. (2023). Analysis of the fecal metagenome in long‐term survivors of pancreas cancer. Cancer. 129(13). 1986–1994. 14 indexed citations
3.
Williamson, Lauren, et al.. (2023). Obesity Alters cytokine signaling and gut microbiome in septic mice. Innate Immunity. 29(8). 161–170. 2 indexed citations
4.
Eshleman, Emily M., Tzu‐Yu Shao, Vivienne Woo, et al.. (2023). Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity. Journal of Clinical Investigation. 133(4). 34 indexed citations
5.
Eshleman, Emily M., Viral G. Jain, David Haslam, et al.. (2023). IEC-intrinsic IL-1R signaling holds dual roles in regulating intestinal homeostasis and inflammation. The Journal of Experimental Medicine. 220(6). 13 indexed citations
6.
Lawson, Matthew, Traci E. Stankiewicz, Jarren R. Oates, et al.. (2023). Thermoneutral Housing Enables Studies of Vertical Transmission of Obesogenic Diet-Driven Metabolic Diseases. Nutrients. 15(23). 4958–4958.
7.
Phelan, Kieran J., Kimberly A. Dill‐McFarland, R. Max Segnitz, et al.. (2023). Airway transcriptome networks identify susceptibility to frequent asthma exacerbations in children. Journal of Allergy and Clinical Immunology. 152(1). 73–83. 6 indexed citations
8.
Courter, Joshua, Philip Hagedorn, David Haslam, et al.. (2022). Aligning Provider Prescribing With Guidelines for Soft Tissue Infections. Pediatric Emergency Care. 38(3). e1063–e1068. 1 indexed citations
9.
Shao, Tzu‐Yu, Jessica N. Witchley, Corey Frazer, et al.. (2022). Candida albicans oscillating UME6 expression during intestinal colonization primes systemic Th17 protective immunity. Cell Reports. 39(7). 110837–110837. 25 indexed citations
10.
Young, J. P. R., Devesh Dahale, Maureen M. O’Brien, et al.. (2020). Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications. Pediatric Blood & Cancer. 67(8). 9 indexed citations
11.
Haberman, Beth, et al.. (2017). Risk Factors for Staphylococcus aureus Acquisition in the Neonatal Intensive Care Unit: A Matched Case-Case-Control Study. Infection Control and Hospital Epidemiology. 39(1). 46–52. 15 indexed citations
12.
Haslam, David. (2015). Why a Hydrographic Office. The International Hydrographic Review. 62(1). 1 indexed citations
13.
Haslam, David. (2012). Nursing home patients are falling through the net.. PubMed. 256(1751). 31–31. 1 indexed citations
14.
Haslam, David & Carel W. le Roux. (2011). Efficiency. A heavyweight answer to obesity.. PubMed. 121(6276). 32–3. 1 indexed citations
15.
Davies, Caroline, et al.. (2003). A national audit of chronic constipation in the community.. PubMed. 99(11). 34–5. 17 indexed citations
16.
Okajima, Tetsuya, Yoko Nakamura, Makoto Uchikawa, et al.. (2000). Expression Cloning of Human Globoside Synthase cDNAs. Journal of Biological Chemistry. 275(51). 40498–40503. 60 indexed citations
17.
Haslam, David. (1992). GPs, social workers and the Mental Health Act.. PubMed. 236(1516). 722–5. 2 indexed citations
18.
Haslam, David. (1979). Costs of unnecessary tests. BMJ. 2(6183). 207.2–207. 1 indexed citations
19.
Haslam, David. (1979). STUDENTS IN NEED: ESSAYS IN MEMORY OF NICOLAS MALLESON. PubMed Central. 29(204). 436–436. 1 indexed citations
20.
Haslam, David. (1978). COUNSELLING PARENTS OF CHILDREN WITH HANDICAPS.. PubMed Central. 28(197). 760–760.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026